D

Dingdang Health Technology Group Ltd
HKEX:9886

Watchlist Manager
Dingdang Health Technology Group Ltd
HKEX:9886
Watchlist
Price: 0.55 HKD 5.77% Market Closed
Market Cap: 726.8m HKD
Have any thoughts about
Dingdang Health Technology Group Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

3.8
Current
-0.6
Median
8.5
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
3.8
=
Enterprise Value
-898.3m HKD
/
EBITDA
-220.1m CNY
All Countries
Close
EBITDA Growth EV/EBITDA to Growth
CN
D
Dingdang Health Technology Group Ltd
HKEX:9886
Average EV/EBITDA: 40.5
3.8
N/A N/A
US
Amazon.com Inc
NASDAQ:AMZN
21
133%
0.2
ZA
N
Naspers Ltd
JSE:NPN
Not Available
1 697%
N/A
CN
Alibaba Group Holding Ltd
NYSE:BABA
10.5
40%
0.3
CN
Pinduoduo Inc
NASDAQ:PDD
6.7
227%
0
CN
Meituan
HKEX:3690
35.6
332%
0.1
NL
Prosus NV
AEX:PRX
Negative Multiple: -588.2 N/A N/A
UY
MercadoLibre Inc
BMV:MELIN
32.1
136%
0.2
AR
Mercadolibre Inc
NASDAQ:MELI
32
136%
0.2
US
D
DoorDash Inc
NASDAQ:DASH
215.8
N/A N/A
CN
JD.Com Inc
HKEX:9618
6.5
74%
0.1

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-17.9
2-Years Forward
EV/EBITDA
-5.9
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More